Stock AnalizLegence Corp. LGN
Engineering & Construction · IPO 2025 · data as of November 13, 2026
Legence Corp. (LGN) is a consumer discretionary company listed in the US with a market value of about $5.4B. In the twelve months to September 30, 2026 it had revenue of $4.3B and net income of $45M, a net margin of 1.0%.
Its overall Stock Analiz score is 1.2 out of 5 (weak). The strongest part is value (2/5); the weakest is track record (0/5).
Key numbers: a P/E of 89.7, a price to free cash flow of 18.2, a 5-year average ROIC of 4%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 91% above the current price.
Score: 1.2 / 5
Checks passed
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- Revenue growth above 10% last year
- Strong R&D investment or growth above 20%
- Positive free cash flow
- Stock-based pay below 5% of revenue
Checks not passed
- P/E below 25
- P/E below the industry median
- PEG below 1.5
- 3-year revenue growth above 10% a year
- Profit margin improving
- 3-year free cash flow growth above 10% a year
- 5-year EPS growth above 10% a year
- 5-year revenue growth above 8% a year
Valuation
Growth and quality
Financials, last 3 years
| Fiscal year | TTM | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $4.3B | $2.6B | $2.1B | $1.6B |
| Net income | $45M | -$60M | -$29M | -$46M |
| Free cash flow | $298M | $219M | $10M | $17M |
| EPS (diluted) | $0.34 | $-0.39 | — | — |
| Net margin | 1.0% | -2.3% | -1.4% | -2.9% |
| ROIC | — | 3.6% | — | — |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 17 analysts is $72.18, 106% above the current price; targets range from $50.00 to $130.00; the consensus rating is “Strong buy”; expected EPS is $2.27 for the fiscal year ending December 31, 2026.
Frequently asked questions
What is Legence’s P/E ratio?
About 89.7, based on the last twelve months of diluted earnings per share (forward P/E about 13.9).
Is Legence stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 91% above the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Legence pay a dividend?
Not currently.
Is Legence a good stock to buy?
We do not give buy or sell advice. Legence scores 1.2 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.